PGEN

Precigen Inc.

Price

$7.16

return (12m)

122.36%

p/e

-14.41

p/bv

52.14

DIVIDEND YIELD

0.00%

PGEN price

Precigen

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PGEN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

31.26%

3 months

67.29%

1 year

122.36%

2 years

522.61%

5 years

27.40%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals PGEN

Valuation

P/E

-14.41

Sector -4.38

Industry -4.38

P/BV

52.14

Sector 2.02

Industry 2.02

P/Revenue (PSR)

26.51

Sector -4.40

Industry -4.40

EV/EBITDA

96.48

Sector -263.09

Industry -263.09

EV/EBIT

101.13

Sector -702.90

Industry -702.90

P/EBITDA

-15.80

Sector -4.39

Industry -4.39

P/EBIT

-15.36

Sector -4.73

Industry -4.73

P/Total Assets

13.34

Sector 1.49

Industry 1.49

P/Net Current Assets

296.65

Sector -11.70

Industry -11.70

P/Working Capital

21.63

Sector -3.19

Industry -3.19

EPS

-0.44

Sector -2.14

Industry -2.14

BVPS

0.12

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

90.67%

Sector 36.74%

Industry 36.74%

EBITDA Margin

43.89%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

41.87%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-46.08%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.32

Sector 0.03

Industry 0.03

Profitability

ROE

-361.86%

Sector -65.14%

Industry -65.14%

ROA

-92.60%

Sector -65.53%

Industry -65.53%

ROIC

101.83%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.58

Sector 2.90

Industry 2.90

Net Debt / EBITDA

2.31

Sector -6.07

Industry -6.07

Net Debt / EBIT

2.42

Sector -8.26

Industry -8.26

Net Debt / Equity

1.28

Sector -1.07

Industry -1.07

Gross Debt / Equity

2.15

Sector -0.05

Industry -0.05

Equity/Assets

0.26

Sector 0.41

Industry 0.41

Liabilities/Assets

0.74

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

19.39%

Sector -

Industry -

5Y Earnings CAGR

11.34%

Sector -

Industry -

Fundamentals PGEN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PGEN Precigen Inc.	$7.16	142.71%	0.00%	-14.41	52.14	-361.86%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PGEN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Precigen

Precigen Inc.

Average Investor10 user rating

4.0 (0 people)

United States

28 years

Founded: 1998

2013

Time since IPO - 13 years

680

Employees

Precigen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.27 billion, with shareholders equity totaling $43.58 million.

The company employs approximately 680 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Precigen Inc. reported $85.72 million in revenue, generating net income of $-157.70 million.

Key financial metrics include a P/E ratio of -14.41, a price-to-book (P/B) ratio of 52.14, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PGEN.

Market cap

$2.27 billion

Net worth

$43.58 million

$43,580,000.00

Assets

$170.30 million

$170,300,000.00

Total Shares Outstanding

357.00 million

357,000,000

Average Daily Trading Volume

$5.28 million

$5,275,326.00

Sector

Health Care

Industry

Biotechnology

PGEN

PGEN revenue and profits

Financial Results PGEN

DRAG THE FRAME TO SEE MORE DATA

PGEN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Precigen (PGEN) today?

A cotação de Precigen (PGEN) hoje está em US$ 7.16, com uma variação de 122.36% em relação ao último ano. A cotação de Precigen (PGEN) iniciou o ano negociando na casa dos US$ 4.18 e hoje está em US$ 7.16. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Precigen (PGEN) e dados de ações do Ibovespa e mercados internacionais.

Quando Precigen (PGEN) paga dividendos?

Precigen (PGEN) não distribuiu dividendos no último ano.

Is Precigen (PGEN) a good investment?

Atualmente, Precigen (PGEN) está cotada a US$ 7.16, com um P/L de -14.41, representando um desvio de -306% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 122.36 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 122.36%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Precigen (PGEN) stock?

Investir em ações de Precigen (PGEN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Precigen (PGEN) yield today?

A rentabilidade de Precigen (PGEN) foi de 31.26% no último mês, 122.36% no último ano e 27.40% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Precigen (PGEN) hoje, o investimento total seria de US$ 716.00, com base na cotação atual de US$ 7.16.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,592.10
Em 5 anos: US$ 912.18
Em 10 anos: US$ 716.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PGEN

Precigen Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PGEN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING PGEN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Precigen

Precigen Inc.

United States

28 years

2013

680

PROFIT X PRICE PGEN

Financial Results PGEN

PGEN cash flow

Asset, Revenue and Profit Growth - PGEN

PGEN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions